117 related articles for article (PubMed ID: 21557636)
1. Peritoneal immune system in patients with advance epithelial ovarian cancer.
Wertel I; Nowicka A; Rogala E; Kotarski J
Int Rev Immunol; 2011; 30(2-3):87-101. PubMed ID: 21557636
[TBL] [Abstract][Full Text] [Related]
2. Higher Numbers of T-Bet+ Tumor-Infiltrating Lymphocytes Associate with Better Survival in Human Epithelial Ovarian Cancer.
Xu Y; Chen L; Xu B; Xiong Y; Yang M; Rui X; Shi L; Wu C; Jiang J; Lu B
Cell Physiol Biochem; 2017; 41(2):475-483. PubMed ID: 28214872
[TBL] [Abstract][Full Text] [Related]
3. PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer.
Webb JR; Milne K; Kroeger DR; Nelson BH
Gynecol Oncol; 2016 May; 141(2):293-302. PubMed ID: 26972336
[TBL] [Abstract][Full Text] [Related]
4. Targeting myeloid cells in the tumor microenvironment enhances vaccine efficacy in murine epithelial ovarian cancer.
Khan AN; Kolomeyevskaya N; Singel KL; Grimm MJ; Moysich KB; Daudi S; Grzankowski KS; Lele S; Ylagan L; Webster GA; Abrams SI; Odunsi K; Segal BH
Oncotarget; 2015 May; 6(13):11310-26. PubMed ID: 25888637
[TBL] [Abstract][Full Text] [Related]
5. Tumor-infiltrating T cells in epithelial ovarian cancer: predictors of prognosis and biological basis of immunotherapy.
Wang W; Zou W; Liu JR
Gynecol Oncol; 2018 Oct; 151(1):1-3. PubMed ID: 30243508
[No Abstract] [Full Text] [Related]
6. Infiltration of dendritic cells and T lymphocytes predicts favorable outcome in epithelial ovarian cancer.
Zhang Z; Huang J; Zhang C; Yang H; Qiu H; Li J; Liu Y; Qin L; Wang L; Hao S; Zhang F; Wang X; Shan B
Cancer Gene Ther; 2015 Mar; 22(4):198-206. PubMed ID: 25721210
[TBL] [Abstract][Full Text] [Related]
7. Myeloid and lymphoid dendritic cells in the peritoneal fluid of women with ovarian cancer.
Wertel F; Polak G; Roliński J; Barczyński B; Kotarski J
Adv Med Sci; 2006; 51():174-7. PubMed ID: 17357302
[TBL] [Abstract][Full Text] [Related]
8. Defective antitumor function of monocyte-derived macrophages from epithelial ovarian cancer patients.
Gordon IO; Freedman RS
Clin Cancer Res; 2006 Mar; 12(5):1515-24. PubMed ID: 16533776
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of myeloid and lymphoid dendritic cells in peritoneal fluid in women with non-malignant ovarian tumors.
Wertel I; Kotarski J; Roliński J; Bojarska-Junak A; Gogacz M
Am J Reprod Immunol; 2003 Sep; 50(3):238-42. PubMed ID: 14629029
[TBL] [Abstract][Full Text] [Related]
10. Study on the mesothelin-specific cytotoxicity against epithelial ovarian cancer with full-length mesothelin cDNA-transduced dendritic cells.
Wang DH; Wu XH; Qian SM; Yao HR
Med Oncol; 2015 Apr; 32(4):116. PubMed ID: 25779534
[TBL] [Abstract][Full Text] [Related]
11. FACS analysis of peritoneal lymphocytes in ovarian cancer and control patients.
Reijnhart RM; Bieber MM; Teng NN
Immunobiology; 1994 Aug; 191(1):1-8. PubMed ID: 7806256
[TBL] [Abstract][Full Text] [Related]
12. Effect of mature dendritic cells primed with autologous tumor antigens from patients with epithelial ovarian cancer on stimulation of the cytotoxic immune response in culture of mononuclear cells.
Obleukhova IA; Kurilin VV; Goncharov MA; Tarkhov AV; Krasil'nikov SE; Sennikov SV
Bull Exp Biol Med; 2013 Nov; 156(1):161-4. PubMed ID: 24319716
[TBL] [Abstract][Full Text] [Related]
13. Macrophage-derived chemokine CCL22 and regulatory T cells in ovarian cancer patients.
Wertel I; Surówka J; Polak G; Barczyński B; Bednarek W; Jakubowicz-Gil J; Bojarska-Junak A; Kotarski J
Tumour Biol; 2015 Jun; 36(6):4811-7. PubMed ID: 25647263
[TBL] [Abstract][Full Text] [Related]
14. Mismatch repair deficiency is associated with MSI phenotype, increased tumor-infiltrating lymphocytes and PD-L1 expression in immune cells in ovarian cancer.
Xiao X; Dong D; He W; Song L; Wang Q; Yue J; Xie L
Gynecol Oncol; 2018 Apr; 149(1):146-154. PubMed ID: 29496294
[TBL] [Abstract][Full Text] [Related]
15. The phenotype of ascitic fluid lymphocytes in patients with ovarian carcinoma and other primaries.
Melichar B; Tousková M; Tosner J; Kopecký O
Onkologie; 2001 Apr; 24(2):156-60. PubMed ID: 11441296
[TBL] [Abstract][Full Text] [Related]
16. Establishment of Primary Cell Culture From Ascitic Fluid and Solid Tumor Obtained From Epithelial Ovarian Carcinoma Patients.
Kar R; Chawla D; Gupta B; Mehndiratta M; Wadhwa N; Agarwal R
Int J Gynecol Cancer; 2017 Nov; 27(9):2000-2005. PubMed ID: 28816710
[TBL] [Abstract][Full Text] [Related]
17. Interaction between Treg cells and tumor-associated macrophages in the tumor microenvironment of epithelial ovarian cancer.
Zhu Q; Wu X; Wu Y; Wang X
Oncol Rep; 2016 Dec; 36(6):3472-3478. PubMed ID: 27748885
[TBL] [Abstract][Full Text] [Related]
18. Ovarian carcinoma-infiltrating regulatory T cells were more potent suppressors of CD8(+) T cell inflammation than their peripheral counterparts, a function dependent on TIM3 expression.
Bu M; Shen Y; Seeger WL; An S; Qi R; Sanderson JA; Cai Y
Tumour Biol; 2016 Mar; 37(3):3949-56. PubMed ID: 26482613
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic and functional analysis of tumor-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and peripheral blood lymphocytes in patients with advanced ovarian cancer.
Santin AD; Hermonat PL; Ravaggi A; Bellone S; Roman JJ; Smith CV; Pecorelli S; Radominska-Pandya A; Cannon MJ; Parham GP
Gynecol Obstet Invest; 2001; 51(4):254-61. PubMed ID: 11408737
[TBL] [Abstract][Full Text] [Related]
20. Do tumor-infiltrating lymphocytes really indicate favorable prognosis in epithelial ovarian cancer?
Yildirim N; Akman L; Acar K; Demir S; Ozkan S; Alan N; Zekioglu O; Terek MC; Ozdemir N; Ozsaran A
Eur J Obstet Gynecol Reprod Biol; 2017 Aug; 215():55-61. PubMed ID: 28601728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
